107. 若年性特発性関節炎 Juvenile idiopathic arthritis Clinical trials / Disease details


臨床試験数 : 447 薬物数 : 297 - (DrugBank : 57) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 146

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04752371
(ClinicalTrials.gov)
March 25, 20219/2/2021A Study to Evaluate Camoteskimab in Participants With Still's Disease (AOSD/sJIA)A Phase 1b/2a, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Camoteskimab in Subjects With Still's Disease (sJIA/AOSD)Adult Onset Still's Disease;Systemic Juvenile Idiopathic ArthritisDrug: Camoteskimab (CERC-007, AVTX-007, AEVI-007)Apollo Therapeutics LtdNULLRecruiting6 Years75 YearsAll20Phase 2United States;Belgium;Poland;Ukraine